Obstructive Hypertrophic Cardiomyopathy

DBCOND0057747Cardiovascular DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Obstructive Hypertrophic Cardiomyopathy is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Hypertrophic Subaortic Stenosis · Hypertrophic Obstructive Cardiomyopathy (HOCM) · Hypertrophic Obstructive Cardiomyopathy · Idiopathic hypertrophic subaortic stenosis · Hypertrophic Cardiomyopathy, Obstructive
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10I42.1SNOMED CT155351008MedDRA10020203UMLSC0007194

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
31Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Obstructive Hypertrophic Cardiomyopathy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In